Design and in vitro release study of siRNA loaded Layer by Layer nanoparticles with sustained gene silencing effect

References

• Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806–811.
   PubMed Web of Science ®Google Scholar
• Leung RKM, Whittaker PA. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther. 2005;107(2):222–239.
   PubMed Web of Science ®Google Scholar
• Wittrup A, Lieberman J. Knocking down disease: a progress report on siRNA therapeutics. Nat Rev Genet. 2015;169:543–552.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Satterlee A, Huang L. In vivo gene delivery by nonviral vectors: overcoming hurdles? Mol Ther. 2012;20(7):1298–1304.
   PubMed Web of Science ®Google Scholar
• Wittrup A, Lieberman J. Knocking down disease: a progress report on siRNA therapeutics. PubMed PMID: PMC4756474 Nat Rev Genet. 2015;169:543–552.
   PubMed Web of Science ®Google Scholar
• Chakraborty C, Sharma AR, Sharma G, et al. Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine. Mol Ther Nucleic Acids. 2017;8:132–143.
   PubMedGoogle Scholar
• Kanasty R, Dorkin JR, Vegas A, et al. Delivery materials for siRNA therapeutics. Nat Mater. 2013;12(11):967–977.
   PubMed Web of Science ®Google Scholar
• Tan YF, Mundargi RC, Chen MHA, et al. Layer‐by‐layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing. Small. 2014;10(9):1790–1798.
   PubMed Web of Science ®Google Scholar
• Jiang B, Barnett JB, Li B. Advances in polyelectrolyte multilayer nanofilms as tunable drug delivery systems. Nanotechnol Sci Appl. 2009;2:21–27.
   PubMedGoogle Scholar
• Deng ZJ, Morton SW, Ben-Akiva E, et al. Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano. 2013;7(11):9571–9584.
   PubMed Web of Science ®Google Scholar
• Ariga K, Lvov YM, Kawakami K, et al. Layer-by-layer self-assembled shells for drug delivery. Adv Drug Deliv Rev. 2011;63(9):762–771.
   PubMed Web of Science ®Google Scholar
• Takabatake Y, Isaka Y, Mizui M, et al. Chemically modified siRNA prolonged RNA interference in renal disease. Biochem Biophys Res Commun. 2007;363(2):432–437.
   PubMed Web of Science ®Google Scholar
• Lee SK, Tung CH. A fabricated sirna nanoparticle for ultralong gene silencing in vivo. Adv Funct Mater. 2013;23(28):3488–3493.
   PubMed Web of Science ®Google Scholar
• Dorozhkin SV. Bioceramics of calcium orthophosphates. Biomaterials. 2010;31(7):1465–1485.
   PubMed Web of Science ®Google Scholar
• Seet L-F, Finger S, Chu S, et al. Novel insight into the inflammatory and cellular responses following experimental glaucoma surgery: a roadmap for inhibiting fibrosis. Curr Mol Med. 2013;13(6):911–928.
   PubMed Web of Science ®Google Scholar
• Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15):5245–5250.
   PubMed Web of Science ®Google Scholar
• Cheng P-C. The contrast formation in optical microscopy. Pawley J. (eds) Handbook of biological confocal microscopy. Springer; 2006. p. 162–206.
   Google Scholar
• Helms V. Principles of computational cell biology – from protein complexes to cellular networks. WILEY-VCH Verlag GmbH & Co. John Wiley & Sons; 2008.
   Google Scholar
• Zheng J. Spectroscopy-based quantitative fluorescence resonance energy transfer analysis. Ion Channels. Methods Protocols. 2006;337:65–77.
   Google Scholar
• Akinc A, Goldberg M, Qin J, et al. Development of lipidoid–siRNA formulations for systemic delivery to the liver. Mol Ther. 2009;17(5):872–879.
   PubMed Web of Science ®Google Scholar
• Uskoković V, Uskoković DP. Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents. J Biomed Mater Res. 2011;96(1):152–191.
   Google Scholar
• Mateus AYP, Barrias CC, Ribeiro C, et al. Comparative study of nanohydroxyapatite microspheres for medical applications. J Biomed Mater Res. 2008;86(2):483–493.
   Google Scholar
• Ferraz M, Mateus A, Sousa J, et al. Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts. J Biomed Mater Res. 2007;81(4):994–1004.
   Google Scholar
• Xu K, Cantu DA, Fu Y, et al. Thiol-ene michael-type formation of gelatin/poly (ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds. Acta Biomater. 2013;9(11):8802–8814.
   PubMed Web of Science ®Google Scholar
• Opanasopit P, Tragulpakseerojn J, Apirakaramwong A, et al. The development of poly-L-arginine-coated liposomes for gene delivery. Int J Nanomedicine. 2011;6:2245–2252.
   PubMed Web of Science ®Google Scholar
• Nemoto E, Ueda H, Akimoto M, et al. Ability of poly-L-arginine to enhance drug absorption into aqueous humor and vitreous body after instillation in rabbits. Biol Pharm Bull. 2007;30(9):1768–1772.
   PubMed Web of Science ®Google Scholar
• Lozano M, Lollo G, Alonso-Nocelo M, et al. Polyarginine nanocapsules: a new platform for intracellular drug delivery. J Nanoparticle Res. 2013;15(3):1515.
   Web of Science ®Google Scholar
• Gonçalves E, Kitas E, Seelig J. Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide. Biochemistry. 2005;44(7):2692–2702.
   PubMed Web of Science ®Google Scholar
• Liu BR, Huang Y-W, Winiarz JG, et al. Intracellular delivery of quantum dots mediated by a histidine-and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. Biomaterials. 2011;32(13):3520–3537.
   PubMed Web of Science ®Google Scholar
• Appelbaum JS, LaRochelle JR, Smith BA, et al. Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm. Chem Biol. 2012;19(7):819–830.
   PubMedGoogle Scholar
• Hohenester E, Sasaki T, Giudici C, et al. Structural basis of sequence-specific collagen recognition by SPARC. Proc Natl Acad Sci. 2008;105(47):18273–18277.
   PubMed Web of Science ®Google Scholar
• Zhou X, Tan FK, Reveille JD, et al. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum. 2002;46(11):2990–2999.
   PubMedGoogle Scholar
• Francki A, Bradshaw AD, Bassuk JA, et al. SPARC regulates the expression of collagen type I and transforming growth factor-β1 in mesangial cells. J Biol Chem. 1999;274(45):32145–32152.
   PubMed Web of Science ®Google Scholar
• Pichler RH, Hugo C, Shankland SJ, et al. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int. 1996;50(6):1978–1989.
   PubMed Web of Science ®Google Scholar
• Kuhn C, Mason RJ. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol. 1995;147(6):1759.
   PubMed Web of Science ®Google Scholar
• Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21(12):1998–2003.
   PubMed Web of Science ®Google Scholar
• Bradshaw AD, Reed MJ, Sage EH. SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochemistry. 2002;50(1):1–10.
   PubMed Web of Science ®Google Scholar
• Reed M, Puolakkainen P, Lane T, et al. Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochemistry. 1993;41(10):1467–1477.
   PubMed Web of Science ®Google Scholar
• Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 1994;8(2):163–173.
   PubMed Web of Science ®Google Scholar
• Zhou X, Tan FK, Guo X, et al. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma. Arthritis Rheum. 2006;54(8):2626–2631.
   PubMedGoogle Scholar
• Camino AM, Atorrasagasti C, Maccio D, et al. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats. J Gene Med. 2008;10(9):993–1004.
   PubMed Web of Science ®Google Scholar
• Seet L-F, Su R, Barathi V, et al. SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery. PLoS One. 2010;5(2):e9415.
   PubMed Web of Science ®Google Scholar
• Phuc L, Taniguchi A. Epidermal growth factor enhances cellular uptake of polystyrene nanoparticles by clathrin-mediated endocytosis. PubMed PMID: Int J Mol Sci. 2017;186:1301.
   Web of Science ®Google Scholar
• Muñoz Javier A, Kreft O, Piera Alberola A, et al. Combined atomic force microscopy and optical microscopy measurements as a method to investigate particle uptake by cells. Small. 2006;2(3):394–400.
   PubMed Web of Science ®Google Scholar
• Vasir JK, Labhasetwar V. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials. 2008;29(31):4244–4252.
   PubMed Web of Science ®Google Scholar
• Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci. 2013;48(3):416–427.
   PubMed Web of Science ®Google Scholar
• Luo R, Neu B, Venkatraman SS. Surface functionalization of nanoparticles to control cell interactions and drug release. Small. 2012;8(16):2585–2594.
   PubMed Web of Science ®Google Scholar
• Nimesh S, Manchanda R, Kumar R, et al. Preparation, characterization and in vitro drug release studies of novel polymeric nanoparticles. Int J Pharm. 2006;323(1):146–152.
   PubMedGoogle Scholar
• Khalil IA, Kogure K, Akita H, et al. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev. 2006;58(1):32–45.
   PubMed Web of Science ®Google Scholar
• Benfer M, Kissel T. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles. Eur J Pharm Biopharm. 2012;80(2):247–256.
   PubMed Web of Science ®Google Scholar
• Huang HW, Chen F-Y, Lee M-T. Molecular mechanism of peptide-induced pores in membranes. Phys Rev Lett. 2004;92(19):198304.
   PubMed Web of Science ®Google Scholar
• Herce HD, Garcia AE, Litt J, et al. Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophys J. 2009;97(7):1917–1925.
   PubMed Web of Science ®Google Scholar
• Morton SW, Herlihy KP, Shopsowitz KE, et al. scalable manufacture of built‐to‐order nanomedicine: spray‐assisted layer‐by‐layer functionalization of PRINT nanoparticles. Adv Mater. 2013;25(34):4707–4713.
   PubMed Web of Science ®Google Scholar
• Richardson JJ, Ejima H, Lörcher SL, et al. Preparation of nano‐and microcapsules by electrophoretic polymer assembly. Angew Chem Int Ed. 2013;52(25):6455–6458.
   PubMed Web of Science ®Google Scholar